View source for 2vcd


==Solution structure of the FKBP-domain of Legionella pneumophila Mip in complex with rapamycin==
<StructureSection load='2vcd' size='340' side='right'caption='[[2vcd]], [[NMR_Ensembles_of_Models | 16 NMR models]]' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[2vcd]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Atcc_33152 Atcc 33152]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VCD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2VCD FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=RAP:RAPAMYCIN+IMMUNOSUPPRESSANT+DRUG'>RAP</scene></td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">mip, lpg0791 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=446 ATCC 33152])</td></tr>
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[https://en.wikipedia.org/wiki/Peptidylprolyl_isomerase Peptidylprolyl isomerase], with EC number [https://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.2.1.8 5.2.1.8] </span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2vcd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2vcd OCA], [https://pdbe.org/2vcd PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2vcd RCSB], [https://www.ebi.ac.uk/pdbsum/2vcd PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2vcd ProSAT]</span></td></tr>
</table>
== Function ==
[[https://www.uniprot.org/uniprot/MIP_LEGPH MIP_LEGPH]] Essential virulence factor associated with macrophage infectivity. Exhibits PPIase activity. 
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/vc/2vcd_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2vcd ConSurf].
<div style="clear:both"></div>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
BACKGROUND: Legionella pneumphila is the causative agent of Legionnaires' disease. A major virulence factor of the pathogen is the homodimeric surface protein Mip. It shows peptidyl-prolyl cis/trans isomerase activty and is a receptor of FK506 and rapamycin, which both inhibit its enzymatic function. Insight into the binding process may be used for the design of novel Mip inhibitors as potential drugs against Legionnaires' disease. RESULTS: We have solved the solution structure of free Mip77-213 and the Mip77-213-rapamycin complex by NMR spectroscopy. Mip77-213 showed the typical FKBP-fold and only minor rearrangements upon binding of rapamycin. Apart from the configuration of a flexible hairpin loop, which is partly stabilized upon binding, the solution structure confirms the crystal structure. Comparisons to the structures of free FKBP12 and the FKBP12-rapamycin complex suggested an identical binding mode for both proteins. CONCLUSION: The structural similarity of the Mip-rapamycin and FKBP12-rapamycin complexes suggests that FKBP12 ligands may be promising starting points for the design of novel Mip inhibitors. The search for a novel drug against Legionnaires' disease may therefore benefit from the large variety of known FKBP12 inhibitors.

Solution structure of the Legionella pneumophila Mip-rapamycin complex.,Ceymann A, Horstmann M, Ehses P, Schweimer K, Paschke AK, Steinert M, Faber C BMC Struct Biol. 2008 Mar 17;8:17. PMID:18366641<ref>PMID:18366641</ref>

From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 2vcd" style="background-color:#fffaf0;"></div>

==See Also==
*[[Peptidyl-prolyl cis-trans isomerase 3D structures|Peptidyl-prolyl cis-trans isomerase 3D structures]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Atcc 33152]]
[[Category: Large Structures]]
[[Category: Peptidylprolyl isomerase]]
[[Category: Ceymann, A]]
[[Category: Ehses, P]]
[[Category: Faber, C]]
[[Category: Fischer, G]]
[[Category: Horstmann, M]]
[[Category: Paschke, A K]]
[[Category: Roesch, P]]
[[Category: Schweimer, K]]
[[Category: Fkbp]]
[[Category: Fkbp-domain]]
[[Category: Isomerase]]
[[Category: Legionella pneumophila]]
[[Category: Legionnaires disease]]
[[Category: Macrolide antibiotic]]
[[Category: Membrane]]
[[Category: Mip]]
[[Category: Outer membrane]]
[[Category: Ppiase]]
[[Category: Rapamycin]]
[[Category: Rotamase]]
[[Category: Sirolimus]]
[[Category: Virulence]]